Good M F, Nossal G J
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1693-7. doi: 10.1073/pnas.80.6.1693.
CBA (H-2k) responder spleen cells have been cultured at limit dilution with trinitrophenyl (TNP)-modified BALB/c (H-2d) stimulator cells and a source of T-cell growth factor in order to generate cytotoxic effector clones. After culture, such clones were split into two to four replicates and each was assayed against a different target. This allowed identification of clones capable of lysing TNP-modified P815 (H-2d) targets but not unmodified P815 targets. Thus, clones specific for TNP and allogeneic restriction elements were detected without the need to use techniques that deplete the responder population of alloreactive cells. Cytotoxic T lymphocyte precursors (CTL-P) specific for TNP-modified P815 (major histocompatibility complex-nonidentical) targets were identified, at a low frequency (28.2 x 10(-6)) compared to CTL-P for TNP-modified C1.18 (H-2k) (identical) targets (224 x 10(-6)). The hapten specificity, H-2 restriction specificity, and Thy-1 status of these clones have been examined. Fourteen percent of CBA CTL-P reactive to TNP-modified P815 targets also showed reactivity to NIP-modified P815 targets, and 86% of CBA clones reactive to TNP-modified P815 targets ("allo-TNP-reactive" clones) failed to show reactivity to TNP-modified C1.18 targets--i.e., showed a restriction preference for allo rather than self. All such H-2d-restricted, TNP-specific clones were uniformly sensitive to anti-Thy-1 antibody and complement. Among the H-2k responders studied, we have not demonstrated CTL-P reactive to TNP-modified syngeneic cells which also react with H-2d cells or NIP-modified H-2d cells among 168 clones analyzed. This suggests that such clones, if present, are relatively rare.
将CBA(H-2k)应答脾细胞与三硝基苯基(TNP)修饰的BALB/c(H-2d)刺激细胞以及T细胞生长因子来源进行有限稀释培养,以产生细胞毒性效应克隆。培养后,将这些克隆分成两到四个复制品,并分别针对不同的靶标进行检测。这使得能够鉴定出能够裂解TNP修饰的P815(H-2d)靶标但不能裂解未修饰的P815靶标的克隆。因此,无需使用耗尽应答群体中同种异体反应性细胞的技术,就可以检测到对TNP和同种异体限制元件具有特异性的克隆。与针对TNP修饰的C1.18(H-2k)(相同)靶标的细胞毒性T淋巴细胞前体(CTL-P)(224×10⁻⁶)相比,针对TNP修饰的P815(主要组织相容性复合体不同)靶标的CTL-P以低频率(28.2×10⁻⁶)被鉴定出来。已经检测了这些克隆的半抗原特异性、H-2限制特异性和Thy-1状态。对TNP修饰的P815靶标有反应的CBA CTL-P中,14%也显示出对NIP修饰的P815靶标的反应性,而对TNP修饰的P815靶标有反应的CBA克隆(“同种异体TNP反应性”克隆)中,86%对TNP修饰的C1.18靶标没有反应性——即显示出对同种异体而非自身的限制偏好。所有这些H-2d限制的、TNP特异性克隆均对抗Thy-1抗体和补体敏感。在所研究的H-2k应答者中,在分析的168个克隆中,我们尚未证明对TNP修饰的同基因细胞有反应且也与H-2d细胞或NIP修饰的H-2d细胞有反应的CTL-P。这表明此类克隆(如果存在)相对罕见。